ストックスクリーナーアプリを入手
22.04
0.27%
0.11
前日終値:
$21.93
開ける：
$22.05
24時間の取引高:
48,992
Relative Volume:
0.07
時価総額：
$11.83B
収益：
$22.44B
当期純損益:
$1.35B
株価収益率:
11.60
EPS:
1.9002
ネットキャッシュフロー:
$2.03B
1週間 パフォーマンス:
+1.95%
1か月 パフォーマンス:
+8.92%
6か月 パフォーマンス:
-5.42%
1年 パフォーマンス:
-23.25%
1日の値動き範囲:
$21.97
$22.11
1週間の範囲:
$20.55
$22.11
52週間の値動き範囲:
$20.02
$29.07
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Compare FMS vs HCA, THC, DVA, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
22.03 | 11.23B | 22.44B | 1.35B | 2.03B | 1.9002 |
HCA
Hca Healthcare Inc
|
366.22 | 80.58B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
164.19 | 14.20B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
193.87 | 12.52B | 13.84B | 1.10B | 1.49B | 10.42 |
EHC
Encompass Health Corp
|
101.63 | 10.23B | 6.07B | 793.80M | 464.40M | 5.9914 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-20 | ダウングレード | Goldman | Buy → Neutral |
| 2025-10-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2025-09-02 | ダウングレード | UBS | Neutral → Sell |
| 2024-12-02 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-11-06 | 開始されました | Berenberg | Buy |
| 2024-01-08 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2023-11-17 | アップグレード | Societe Generale | Hold → Buy |
| 2023-08-14 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | 再開されました | Citigroup | Neutral |
| 2023-07-12 | 開始されました | Goldman | Buy |
| 2023-03-07 | 開始されました | Bernstein | Mkt Perform |
| 2023-01-03 | ダウングレード | Jefferies | Buy → Underperform |
| 2022-10-26 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-10-10 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-27 | アップグレード | Jefferies | Underperform → Buy |
| 2022-02-11 | ダウングレード | Jefferies | Hold → Underperform |
| 2021-11-23 | 開始されました | HSBC Securities | Hold |
| 2021-11-11 | アップグレード | Jefferies | Underperform → Hold |
| 2021-02-04 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-02-03 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2020-05-20 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | アップグレード | Jefferies | Hold → Buy |
| 2019-06-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | アップグレード | UBS | Neutral → Buy |
| 2018-08-28 | アップグレード | HSBC Securities | Hold → Buy |
| 2018-07-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | アップグレード | UBS | Sell → Neutral |
| 2017-12-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | アップグレード | Citigroup | Neutral → Buy |
| 2016-07-08 | アップグレード | Jefferies | Underperform → Hold |
| 2016-01-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2015-11-04 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | アップグレード | Goldman | Neutral → Buy |
| 2015-08-13 | ダウングレード | Societe Generale | Buy → Hold |
| 2015-07-31 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | 繰り返されました | Feltl & Co. | Hold |
| 2013-01-14 | アップグレード | HSBC Securities | Neutral → Overweight |
すべてを表示
Fresenius Medical Care Ag Adr (FMS) 最新ニュース
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis - Fresenius Medical Care
The Ogden Water Project: Community Conservation - Fresenius Medical Care
Fresenius Medical Care launches €600M share buyback tranche By Investing.com - Investing.com India
Fresenius Medical Care launches €600M share buyback tranche - Investing.com
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million - Fresenius Medical Care
Ready4 Ci-Ca: Innovation in clinical education - Fresenius Medical Care
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026 - Fresenius Medical Care
Fresenius Medical Care announces €1 billion share buyback program - Investing.com
Fresenius Medical Care at the 63rd ERA Congress - Fresenius Medical Care
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months - Fresenius Medical Care
FMS Stock Price, Quote & Chart | FRESENIUS MEDICAL CARE-ADR (NYSE:FMS) - ChartMill
Research in Brief: Online hemodiafiltration and medium cut-off dialyzers - Fresenius Medical Care
Fresenius Medical Care stock (DE0005785802): Dividend vote and guidance shape the 2026 setup - AD HOC NEWS
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care - Fresenius Medical Care
Fresenius Medical Care stock (DE0005785802): New focus on dialysis demand and margin discipline - AD HOC NEWS
Fresenius Medical Care reappoints CFO Martin Fischer until 2031 - Investing.com
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer - Morningstar
Fresenius Medical Care stock (DE0005785802): dialysis specialist in focus after latest quarterly upd - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): earnings update and strategy focus - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): New dialysis trends keep the company in focus - AD HOC NEWS
Fresenius Medical Care: Shares Look Attractive, Despite Market Uncertainty Around Margin Trajectory - Morningstar
Fresenius Medical Care AG (FMS) Stock Price, Trades & News - GuruFocus
Fresenius SE & Co. KGaA stock (DE0005785604): Global healthcare giant with US dialysis exposure - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Dialysis giant faces headwinds and opportunities in 202 - AD HOC NEWS
Fresenius Medical Care Q1 2026 slides: margin expansion amid revenue pressures - Investing.com Australia
Fresenius Medical Care Q1 2026 slides: margin expansion amid revenue pressures By Investing.com - Investing.com South Africa
Fresenius Medical Care's Margin Improvement Looks Just Paused in 2026, Not Over - Morningstar
Earnings call transcript: Fresenius Medical Care Q1 2026 beats EPS expectations - Investing.com
Fresenius Medical Care Q1 shares fall on U.S. treatment slowdown - Investing.com
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed - Fresenius Medical Care
Fresenius Medical Care stock (DE0005785802): Is chronic kidney disease demand strong enough to unloc - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Why Google Discover changes matter more now - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Is U.S. dialysis dominance still the key growth engine? - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Why U.S. dialysis demand now drives the real value test - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Is U.S. dialysis dominance still the key growth lever? - AD HOC NEWS
Research in Brief: Immunosuppressive therapies in kidney transplant recipients - Fresenius Medical Care
Fresenius Medical Care Sets May 21, 2026 AGM With Dividend and New Buyback Mandate on Agenda - TipRanks
Fresenius Medical Care (NYSE: FMS) plans €1.49 dividend and renews 10% buyback mandate - Stock Titan
Fresenius Medical Care stock: What you should know now before buying - AD HOC NEWS
Supporting living donors through the Circle of Excellence - Fresenius Medical Care
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
Fresenius Medical Care stock advances FME Reignite strategy with Interwell Health investment amid st - AD HOC NEWS
Research in Brief: Population Characteristics in Randomized Trials for HDF - Fresenius Medical Care
10 New 5-Star Stocks This Week - Morningstar
Fresenius Medical Care publishes its Annual Report 2025: The power of care - Fresenius Medical Care
Research round-up: Innovation that moves kidney care forward - Fresenius Medical Care
Advancing kidney care: Introducing high-volume hemodiafiltration to the U.S. - Fresenius Medical Care
Fresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities - Morningstar
Fresenius Medical Care marks World Kidney Day and National Kidney Month - Fresenius Medical Care
Fresenius Medical Care's 2030 Ambition: Navigating a Pivotal Transition () - aktiencheck.de
Fresenius Medical Care: An Undervalued Stock to Buy Now and Hold for the Long Term - Morningstar
Fresenius Medical Care Ag Adr (FMS) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.88%
大文字化:
|
ボリューム (24 時間):